Design Therapeutics
DSGN
DSGN
97 hedge funds and large institutions have $244M invested in Design Therapeutics in 2023 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 30 increasing their positions, 43 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
30% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 43
67% less call options, than puts
Call options by funds: $12K | Put options by funds: $36K
Holders
97
Holding in Top 10
1
Calls
$12K
Puts
$36K
Top Buyers
| 1 | +$9.85M | |
| 2 | +$1.17M | |
| 3 | +$925K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$884K |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$841K |
Top Sellers
| 1 | -$3.22M | |
| 2 | -$2.02M | |
| 3 | -$1.89M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.56M |
| 5 |
BlackRock
New York
|
-$1.21M |